PlGF from breast cancer cell lines also appeared as a critical factor in the promotion of CD34+ hematopoietic progenitor differentiation into tumor-mobilized CD11b+ myeloid cells, endowed with proangiogenic effects (i.e., formation of capillary-like tube structures in vitro and neovessels in vivo). The gene discussed is PGF; the disease is breast carcinoma.